keyword
MENU ▼
Read by QxMD icon Read
search

anticoagulate biomarker

keyword
https://www.readbyqxmd.com/read/30318508/d-dimer-and-high-sensitivity-c-reactive-protein-levels-to-predict-venous-thromboembolism-recurrence-after-discontinuation-of-anticoagulation-for-cancer-associated-thrombosis
#1
Luis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, Maria Isabel Asensio-Cruz, Isabel Blasco-Esquivias, Veronica Sanchez-Lopez, Maria Rodriguez de la Borbolla, Elena Arellano-Orden, Lionel Suarez-Valdivia, Samira Marin-Romero, Lucia Marin-Barrera, Aranzazu Ruiz-Garcia, Emilio Montero-Romero, Silvia Navarro-Herrero, Jose Luis Lopez-Campos, Maria Pilar Serrano-Gotarredona, Juan Manuel Praena-Fernandez, Jose Maria Sanchez-Diaz, Remedios Otero-Candelera
BACKGROUND: Optimal duration of anticoagulation for cancer-associated thrombosis (CAT) remains unclear. This study assessed D-dimer (DD) and high-sensitivity C-reactive protein (hs-CRP) levels after the withdrawal of anticoagulation treatment to predict the risk of venous thromboembolism (VTE) recurrence among patients with CAT. METHODS: Prospective, multicentre study to evaluate CAT with ≥3 months of anticoagulation that was subsequently discontinued. Blood samples were taken when patients stopped the anticoagulation and 21 days later to determine the DD and hs-CRP levels...
October 15, 2018: British Journal of Cancer
https://www.readbyqxmd.com/read/30269144/international-survey-on-the-management-of-acute-kidney-injury-and-continuous-renal-replacement-therapies-year-2018
#2
Kumar Digvijay, Mauro Neri, Weixuan Fan, Zaccaria Ricci, Claudio Ronco
INTRODUCTION: Definition, prevention, and management of acute kidney injury (AKI) and the optimal prescription and delivery of renal replacement therapy (RRT) are currently matters of ongoing discussion. Due to the lack of definitive published literature, a wide gap might exist between routine clinical practice and available recommendations. The aim of this survey was to explore the clinical approach to AKI and RRT in a broad population of nephrologists and intensivists participating in the 36th International course on AKI and Continuous RRT (CRRT), held in Vicenza in June 2018...
September 28, 2018: Blood Purification
https://www.readbyqxmd.com/read/30213470/-acute-pulmonary-embolism-in-the-emergency-department-what-do-the-guidelines-say
#3
Nicolas Meneveau
The therapeutic strategy of acute pulmonary embolism (PE) is based on risk stratification of early mortality in the emergency department. Anticoagulant therapy should be given to all PE patients as early as possible, and direct oral anticoagulants are expected to replace vitamin K antagonists in the majority of cases. The use of a reperfusion strategy should always be considered in patients with high-risk PE defined as PE with clinical hemodynamic instability. Surgical or percutaneous embolectomy is an alternative in case of contraindication to thrombolytic therapy in these patients...
September 10, 2018: La Presse Médicale
https://www.readbyqxmd.com/read/30210653/polypharmacological-profiles-underlying-the-antitumor-property-of-salvia-miltiorrhiza-root-danshen-interfering-with-nox-dependent-neutrophil-extracellular-traps
#4
Li Tao, Min Xu, Xiaojun Dai, Tengyang Ni, Dan Li, Feng Jin, Haibo Wang, Lide Tao, Bo Pan, James R Woodgett, Yayun Qian, Yanqing Liu
Danshen, the dried root of Salvia miltiorrhiza , one of the most investigated medicinal plants with well-defined phytochemical constituents, has shown prominent clinical outcomes for antioxidant, anti-inflammatory, and anticoagulant activities to attain vascular protection and additional benefits for cancer therapy. More recently, activation of neutrophil and excessive formation of neutrophil extracellular traps (NETs) have been observed in pathological conditions of metastatic cancers; thus, we hypothesized that suppression of NETs could account for an essential cellular event underlying Danshen-mediated reduction of the incidence of metastasis...
2018: Oxidative Medicine and Cellular Longevity
https://www.readbyqxmd.com/read/30209626/the-clinical-dilemma-of-anticoagulation-use-in-patients-with-cerebral-amyloid-angiopathy-and-atrial-fibrillation
#5
REVIEW
Rocco J Cannistraro, James F Meschia
PURPOSE OF REVIEW: This review highlights current management of patients with concomitant cerebral amyloid angiopathy (CAA) and atrial fibrillation (AF). We review quantifying risk of ischemic and hemorrhagic stroke as well as treatments to minimize future risk. RECENT FINDINGS: Ischemic stroke risk in AF can be quantified by CHA2 DS2 -VASc and assessing left atrial echocardiographic characteristics. Patients deemed not low risk by CHA2 DS2 -VASC should be anticoagulated...
September 12, 2018: Current Cardiology Reports
https://www.readbyqxmd.com/read/30196789/the-atrial-cardiopathy-and-antithrombotic-drugs-in-prevention-after-cryptogenic-stroke-randomized-trial-rationale-and-methods
#6
Hooman Kamel, W T Longstreth, David L Tirschwell, Richard A Kronmal, Joseph P Broderick, Yuko Y Palesch, Caitlyn Meinzer, Catherine Dillon, Irene Ewing, Judith A Spilker, Marco R Di Tullio, Eldad A Hod, Elsayed Z Soliman, Seemant Chaturvedi, Claudia S Moy, Scott Janis, Mitchell Sv Elkind
Rationale Recent data suggest that a thrombogenic atrial substrate can cause stroke in the absence of atrial fibrillation. Such an atrial cardiopathy may explain some proportion of cryptogenic strokes. Aims The aim of the ARCADIA trial is to test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in subjects with cryptogenic ischemic stroke and atrial cardiopathy. Sample size estimate 1100 participants. Methods and design Biomarker-driven, randomized, double-blind, active-control, phase 3 clinical trial conducted at 120 U...
September 10, 2018: International Journal of Stroke: Official Journal of the International Stroke Society
https://www.readbyqxmd.com/read/30178738/selecting-pregnant-or-postpartum-women-with-suspected-pulmonary-embolism-for-diagnostic-imaging-the-dipep-diagnostic-study-with-decision-analysis-modelling
#7
Steve Goodacre, Kimberley Horspool, Neil Shephard, Daniel Pollard, Beverley J Hunt, Gordon Fuller, Catherine Nelson-Piercy, Marian Knight, Steven Thomas, Fiona Lecky, Judith Cohen
BACKGROUND: Pulmonary embolism (PE) is a leading cause of death in pregnancy and post partum, but the symptoms of PE are common in normal pregnancy. Simple diagnostic tests are needed to select women for diagnostic imaging. OBJECTIVE: To estimate the accuracy, effectiveness and cost-effectiveness of clinical features, decision rules and biomarkers for selecting pregnant or postpartum women with a suspected PE for imaging. DESIGN: An expert consensus study to develop new clinical decision rules, a case-control study of women with a diagnosed PE or a suspected PE, a biomarker study of women with a suspected PE or diagnosed deep-vein thrombosis (DVT) and decision-analysis modelling...
August 2018: Health Technology Assessment: HTA
https://www.readbyqxmd.com/read/30177049/mean-platelet-volume-values-in-preeclampsia-a-systematic-review-and-meta-analysis
#8
REVIEW
Ioannis Bellos, Georgia Fitrou, Vasilios Pergialiotis, Nikolaos Papantoniou, Georgios Daskalakis
OBJECTIVE: Mean platelet volume (MPV) has been explored in several observational studies in the field of preeclampsia and current evidence seem to be conflicting. The purpose of the present meta-analysis is to evaluate the reported MPV differences in patients that develop preeclampsia and to compare them to those of otherwise healthy women. DESIGN AND METHODS: We searched the international literature using the Medline (1966-2018), Scopus (2004-2018), EMBASE (1947-2018) and Clinicaltrials...
July 2018: Pregnancy Hypertension
https://www.readbyqxmd.com/read/30172999/complement-component-consumption-in-sepsis-correlates-better-with-hemostatic-system-parameters-than-with-inflammatory-biomarkers
#9
Dajana Lendak, Dunja Mihajlovic, Gorana Mitic, Milan Ubavic, Aleksandra Novakov-Mikic, Jasmina Boban, Snežana Brkic
INTRODUCTION: The aim of this study was to investigate the role of C3 and C4 complement components in prediction of sepsis outcome. The secondary aim was to determine relationship between complement components and other inflammatory parameters, and parameters of hemostasis. METHODS: One-hundred-thirty-seven patients with sepsis (Sepsis-3 criteria) were included in the study. Routine laboratory markers, predictive APACHEII and SOFA scores, concentrations of C3 and C4, activated partial thromboplastin time (aPTT), prothrombin time (PT), thrombin time (TT), fibrinogen, antithrombin (AT), protein C (PC), protein S (PS), endogenous thrombin potential (ETP), thrombomodulin, and D-dimer were available...
October 2018: Thrombosis Research
https://www.readbyqxmd.com/read/30172264/-value-of-coagulation-and-fibrinolysis-biomarker-in-lung-cancer-patients-with-thromboembolism
#10
Yang Fu, Yumei Liu, Yaxiong Jin, Hong Jiang
BACKGROUND: Coagulation and fibrinolysis biomarkers can effectively reflect the dysfunction of coagulation and anticoagulation system, and the changes of their levels were closely related to the hypercoagulable status. The aim of this study is to study the variation tendency of these coagulation and fibrinolysis markers and explore the diagnosis power and clinical value of these biomarker for thrombosis in postoperative lung cancer patients with deep vein catheterization. METHODS: We selected 118 postoperative lung cancer patients with deep vein catheterization including 29 patients with thromboembolism and 89 patients in control group...
August 20, 2018: Zhongguo Fei Ai za Zhi, Chinese Journal of Lung Cancer
https://www.readbyqxmd.com/read/30151818/long-term-bleeding-risk-prediction-in-real-world-patients-with-atrial-fibrillation-comparison-of-the-has-bled-and-abc-bleeding-risk-scores
#11
María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Vanessa Roldán, Vicente Vicente, Mariano Valdés, Francisco Marín, Gregory Y H Lip
Risk scores in patients with atrial fibrillation (AF) based on clinical factors alone generally have only modest predictive value for predicting high risk patients that sustain events. Biomarkers might be an attractive prognostic tool to improve bleeding risk prediction. The new ABCBleeding score performed better than HAS-BLED score in a clinical trial cohort but has not been externally validated. The aim of this study was to analyze the predictive performance of the ABC-Bleeding score compared to HAS-BLED score in an independent "real-world" anticoagulated AF patients with long-term follow-up...
October 2017: Thrombosis and Haemostasis
https://www.readbyqxmd.com/read/30144017/biomarkers-of-thrombosis-in-st-segment-elevation-myocardial-infarction-a-substudy-of-the-atoll-trial-comparing-enoxaparin-versus-unfractionated-heparin
#12
Johanne Silvain, Stephen A O'Connor, Yan Yan, Mathieu Kerneis, Marie Hauguel-Moreau, Michel Zeitouni, Pavel Overtchouk, Annick Ankri, Delphine Brugier, Eric Vicaut, Patrick Ecollan, Sophie Galier, Jean-Philippe Collet, Gilles Montalescot
BACKGROUND: The aim was to compare the peri-procedural biomarkers of coagulation and platelet activation in patients randomly allocated to intravenous enoxaparin or unfractionated heparin (UFH) in the ATOLL randomized trial (NCT00718471). METHODS AND RESULTS: A total of 129 patients (n = 58 enoxaparin and n = 71 UFH) admitted for ST-segment elevation myocardial infarction (STEMI) treated by percutaneous coronary intervention (PCI) were included in this substudy of the ATOLL trial...
August 25, 2018: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://www.readbyqxmd.com/read/30099654/added-value-of-non-criteria-antiphospholipid-antibodies-for-antiphospholipid-syndrome-lessons-learned-from-year-long-routine-measurements
#13
Polona Žigon, Anuška Podovšovnik, Aleš Ambrožič, Matija Tomšič, Alojzija Hočevar, Nataša Gašperšič, Žiga Rotar, Sonja Praprotnik, Snežna Sodin Šemrl, Saša Čučnik
The international classification criteria for definite antiphospholipid syndrome (APS) include three laboratory measurements: lupus anticoagulant (LA), IgG and IgM isotypes of anti-cardiolipin (aCL) and anti-β2glycoprotein I antibodies (anti-β2GPI). When persistently elevated, they are specific for APS; however, many patients that fulfil clinical criteria may exhibit negative serological results. These "seronegative" APS (SN-APS) are exposed to an increased thrombotic risk. The aims of our cross-sectional, retrospective study of consecutive autoimmune patients' samples were to evaluate the association of non-criteria antiphospholipid antibodies (aPL) with thrombosis and obstetric events, to calculate the risk score for adverse events and to assess the specific contribution of single aPL positivity in SN-APS...
August 11, 2018: Clinical Rheumatology
https://www.readbyqxmd.com/read/30058959/rationale-design-and-baseline-participant-characteristics-in-the-mri-and-cognitive-substudy-of-the-cardiovascular-outcomes-for-people-using-anticoagulation-strategies-trial
#14
Mukul Sharma, Robert G Hart, Eric E Smith, Jackie Bosch, Fei Yuan, Amparo Casanova, John W Eikelboom, Stuart J Connolly, Gloria Wong, Rafael Diaz, Patricio Lopez-Jaramillo, Georg Ertl, Stefan Störk, Gilles R Dagenais, Eva M Lonn, Lars Ryden, Andrew M Tonkin, John D Varigos, Deepak L Bhatt, Kelley Rh Branch, Jeffrey L Probstfield, Jae-Hyung Kim, Jong-Won Ha, Martin O'Donnell, Dragos Vinereanu, Keith Aa Fox, Yan Liang, Lisheng Liu, Jun Zhu, Nana Pogosova, Aldo P Maggioni, Alvaro Avezum, Leopoldo S Piegas, Katalin Keltai, Matyas Keltai, Nancy Cook Bruns, Scott Berkowitz, Salim Yusuf
Background Covert vascular disease of the brain manifests as infarcts, white matter hyperintensities, and microbleeds on MRI. Their cumulative effect is often a decline in cognition, motor impairment, and psychiatric disorders. Preventive therapies for covert brain ischemia have not been established but represent a huge unmet clinical need. Aims The MRI substudy examines the effects of the antithrombotic regimens in COMPASS on incident covert brain infarcts (the primary outcome), white matter hyperintensities, and cognitive and functional status in a sample of consenting COMPASS participants without contraindications to MRI...
July 30, 2018: International Journal of Stroke: Official Journal of the International Stroke Society
https://www.readbyqxmd.com/read/30056785/case-report-and-systematic-review-of-pulmonary-embolism-mimicking-st-elevation-myocardial-infarction
#15
Pedro A Villablanca, Peter P Vlismas, Tatsiana Aleksandrovich, Arthur Omondi, Tanush Gupta, David F Briceno, Mario J Garcia, Jose Wiley
Background To study trends in the clinical presentation, electrocardiograms, and diagnostic imaging in patients with pulmonary embolism presenting as ST segment elevation. Methods We performed a systematic literature search for all reported cases of pulmonary embolism mimicking ST-elevation myocardial infarction. Pre-specified data such as clinical presentation, electrocardiogram changes, transthoracic echocardiographic findings, cardiac biomarkers, diagnostic imaging, therapy, and outcomes were collected. Results We identified a total of 34 case reports...
July 30, 2018: Vascular
https://www.readbyqxmd.com/read/30053822/unusual-case-of-chronic-recurrent-multifocal-osteomyelitis
#16
Ausra Snipaitiene, Rima Sileikiene, Justina Klimaite, Edita Jasinskiene, Rimantas Uktveris, Lina Jankauskaite
BACKGROUND: Chronic recurrent multifocal osteomyelitis (CRMO) is a rare auto-inflammatory bone disorder that primarily affects young girls, with a mean age of 10 years at onset. Generally, it is a self-limited disease. However, recent data indicate that more than 50% of patients have a chronic persistent disease and about 20% a recurring course of this condition. Also, there are more cases reported with associated auto-inflammatory and autoimmune diseases. In this case report, we present a rare case of sporadic CRMO in which the patient eventually developed C-ANCA (cytoplasmic anti-neutrophil cytoplasmic antibodies)-associated renal vasculitis and hyperparathyroidism...
July 27, 2018: Pediatric Rheumatology Online Journal
https://www.readbyqxmd.com/read/30039233/management-of-venous-thromboembolism-in-pregnancy
#17
REVIEW
Annemarie E Fogerty
PURPOSE OF REVIEW: This manuscript addresses the risks for venous thromboembolism (VTE) during pregnancy and the associated challenges of both diagnosis and treatment. RECENT FINDINGS: The obstacles to diagnosis given lack of specificity of typical biomarkers to predict VTE in pregnancy, as well as the unique fetal and bleeding risks introduced by managing massive pulmonary embolism (PE) with thrombolytics or thrombectomy are highlighted. VTE during pregnancy and the postpartum window occurs at a 6-10-fold higher rate compared with age-matched peers and is a major cause of morbidity and mortality...
July 23, 2018: Current Treatment Options in Cardiovascular Medicine
https://www.readbyqxmd.com/read/29967898/-serratia-marcescens-sepsis-in-a-child-with-deep-venous-thrombosis-a-case-report
#18
Iulia Armean, Carmen Duicu, Cornel Aldea, Lorena Melit
Introduction: Venous thromboembolism is a rare condition in paediatrics that included both deep venous thrombosis and pulmonary embolism. Serratia marcescens is a gram-negative bacterium that belongs to the Enterobacteriaceae family and tends to affect immunocompromised hosts. Case report: We report the case of an 11-year-old boy, admitted in the Pediatric Clinic I from Emergency County Hospital Tîrgu Mureş, Romania with intense pain, swelling, cyanosis and claudication of the left foot...
January 2018: Journal of Critical Care Medicine
https://www.readbyqxmd.com/read/29964323/discovery-of-novel-plasma-biomarkers-for-future-incident-venous-thromboembolism-by-untargeted-synchronous-precursor-selection-mass-spectrometry-proteomics
#19
S B Jensen, K Hindberg, T Solomon, E N Smith, J D Lapek, D J Gonzalez, N Latysheva, K A Frazer, S K Braekkan, J-B Hansen
Essentials Discovery of predictive biomarkers of venous thromboembolism (VTE) may aid risk stratification. A case-control study where plasma was sampled before the occurrence of VTE was established. We generated untargeted plasma proteomic profiles of 200 individuals by use of mass spectrometry. Assessment of the biomarker potential of 501 proteins yielded 46 biomarker candidates. ABSTRACT: Background Prophylactic anticoagulant treatment may substantially reduce the incidence of venous thromboembolism (VTE) but entails considerable risk of severe bleeding...
September 2018: Journal of Thrombosis and Haemostasis: JTH
https://www.readbyqxmd.com/read/29956554/left-atrial-thrombus-resolution-in-non-valvular-atrial-fibrillation-or-flutter-biomarker-substudy-results-from-a-prospective-study-with-rivaroxaban-x-tra
#20
Kazuo Miyazawa, Daniele Pastori, Christoph Hammerstingl, Riccardo Cappato, Isabelle Ling Meng, Frank Kramer, Ariel Cohen, Anke Schulz, Martin van Eickels, Gregory Y H Lip, Francisco Marin
BACKGROUND: Non-vitamin K antagonist oral anticoagulants including rivaroxaban are widely used for stroke prevention in patients with atrial fibrillation (AF). We investigated the relationship between plasma biomarkers (indicative of thrombogenesis, fibrinolysis and inflammation) and left atrial thrombus resolution after rivaroxaban treatment. METHODS: This was an ancillary analysis of the X-TRA study, which was a prospective interventional study evaluating the use of rivaroxaban for left atrial/left atrial appendage (LA/LAA) thrombus resolution in AF patients...
June 29, 2018: Annals of Medicine
keyword
keyword
169989
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"